Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03849963 · ClinicalTrials.gov registry record
Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain
A clinical trial of Brain Metabolism, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 28
- Enrollment target
- 1
- Study location
NCT03849963 is a study of Brain Metabolism that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 28 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03849963, a study of Brain Metabolism, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesis of a neurotransmitter in this observational study.
Conditions Studied
Study Locations (1)
Texas
- UT Southwestern - Advanced Imaging Research Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2030-07-30 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03849963
The ClinicalTrials.gov registry entry for NCT03849963 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Metabolism appearing as the primary indexed condition, and to 0 interventions.
NCT03849963 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03849963 about?
NCT03849963 is a clinical study titled "Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain". Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral metabolism: oxidative metabolism and synthesis of a neurotransmitter in this observational study.
What is the current status of trial NCT03849963?
This trial is currently recruiting. The enrollment target is 28 participants. The study started on 2030-07-30. Estimated completion is 2030-12-31.
What conditions does trial NCT03849963 study?
This clinical trial studies the following conditions: Brain Metabolism.
Who is sponsoring clinical trial NCT03849963?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03849963 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.